Close Menu
Advertisement
Subscribe
[the_ad id="32629"]
Acute Lymphoblastic Leukemia

PD1 and CTLA4 Inhibition in RCC

Editor By No Comments1 Min Read

Hans Hammers MD, PhD, Kidney Cancer Program, UT Southwestern presents PD1 and CTLA4 Inhibition in RCC at the 2016 annual International Kidney Cancer Symposium.

Share.

Related Posts